51 research outputs found

    The Grizzly, October 16, 1987

    Get PDF
    Campus Crackdown Affects All ā€¢ Police to Halt Under-Age Drinking ā€¢ Rafuse Paint Crew: Loud, Leering and Surly? ā€¢ Students Study Abroad ā€¢ Musser Returns to Dark Ages ā€¢ Letter: Grizzly Errs ā€¢ G.E. Attends U.C. Luncheon ā€¢ The International Job Scene ā€¢ Commuter Communication Gap ā€¢ Bears Hope for Winning Season ā€¢ Soccer Sinks Washington ā€¢ Athlete of the Week: Walder Forwards Record ā€¢ Meet the 1987 Homecoming Queen Candidates ā€¢ Football to Face Gettysburg ā€¢ Hockey Halted by West Chester ā€¢ Myrin Catalog System On Line ā€¢ Busie Body Needs a Bodyhttps://digitalcommons.ursinus.edu/grizzlynews/1196/thumbnail.jp

    Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease

    Get PDF
    The worldwide burden of sickle cell disease is enormous, with over 200,000 infants born with the disease each year in Africa alone. Induction of fetal hemoglobin is a validated strategy to improve symptoms and complications of this disease. The development of targeted therapies has been limited by the absence of discrete druggable targets. We developed a unique bead-based strategy for the identification of inducers of fetal hemoglobin transcripts in primary human erythroid cells. A small-molecule screen of bioactive compounds identified remarkable class-associated activity among histone deacetylase (HDAC) inhibitors. Using a chemical genetic strategy combining focused libraries of biased chemical probes and reverse genetics by RNA interference, we have identified HDAC1 and HDAC2 as molecular targets mediating fetal hemoglobin induction. Our findings suggest the potential of isoform-selective inhibitors of HDAC1 and HDAC2 for the treatment of sickle cell disease

    The Spill-Over Impact of the Novel Coronavirus-19 Pandemic on Medical Care and Disease Outcomes in Non-communicable Diseases: A Narrative Review

    Get PDF
    OBJECTIVES: The coronavirus-19 (COVID-19) pandemic has claimed more than 5 million lives worldwide by November 2021. Implementation of lockdown measures, reallocation of medical resources, compounded by the reluctance to seek help, makes it exceptionally challenging for people with non-communicable diseases (NCD) to manage their diseases. This review evaluates the spill-over impact of the COVID-19 pandemic on people with NCDs including cardiovascular diseases, cancer, diabetes mellitus, chronic respiratory disease, chronic kidney disease, dementia, mental health disorders, and musculoskeletal disorders. METHODS: Literature published in English was identified from PubMed and medRxiv from January 1, 2019 to November 30, 2020. A total of 119 articles were selected from 6,546 publications found. RESULTS: The reduction of in-person care, screening procedures, delays in diagnosis, treatment, and social distancing policies have unanimously led to undesirable impacts on both physical and psychological health of NCD patients. This is projected to contribute to more excess deaths in the future. CONCLUSION: The spill-over impact of COVID-19 on patients with NCD is just beginning to unravel, extra efforts must be taken for planning the resumption of NCD healthcare services post-pandemic

    Endometrial scratching in women undergoing IVF/ICSI : an individual participant data meta-analysis

    Get PDF
    Funding No specific funding was sought for this project. The sponsor of this project is the University Medical Center Utrecht (UMC Utrecht), Utrecht, the Netherlands. The sponsor was not involved in the study design, data interpretation, or writing of the manuscript.Peer reviewedPublisher PD

    Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis

    Get PDF
    Background: High throughput single-cell RNA sequencing (scRNA-Seq) has emerged as a powerful tool for exploring cellular heterogeneity among complex human cancers. scRNA-Seq studies using fresh human surgical tissue are logistically difficult, preclude histopathological triage of samples, and limit the ability to perform batch processing. This hindrance can often introduce technical biases when integrating patient datasets and increase experimental costs. Although tissue preservation methods have been previously explored to address such issues, it is yet to be examined on complex human tissues, such as solid cancers and on high throughput scRNA-Seq platforms. Methods: Using the Chromium 10X platform, we sequenced a total of ~ 120,000 cells from fresh and cryopreserved replicates across three primary breast cancers, two primary prostate cancers and a cutaneous melanoma. We performed detailed analyses between cells from each condition to assess the effects of cryopreservation on cellular heterogeneity, cell quality, clustering and the identification of gene ontologies. In addition, we performed single-cell immunophenotyping using CITE-Seq on a single breast cancer sample cryopreserved as solid tissue fragments. Results: Tumour heterogeneity identified from fresh tissues was largely conserved in cryopreserved replicates. We show that sequencing of single cells prepared from cryopreserved tissue fragments or from cryopreserved cell suspensions is comparable to sequenced cells prepared from fresh tissue, with cryopreserved cell suspensions displaying higher correlations with fresh tissue in gene expression. We showed that cryopreservation had minimal impacts on the results of downstream analyses such as biological pathway enrichment. For some tumours, cryopreservation modestly increased cell stress signatures compared to freshly analysed tissue. Further, we demonstrate the advantage of cryopreserving whole-cells for detecting cell-surface proteins using CITE-Seq, which is impossible using other preservation methods such as single nuclei-sequencing. Conclusions: We show that the viable cryopreservation of human cancers provides high-quality single-cells for multiomics analysis. Our study guides new experimental designs for tissue biobanking for future clinical single-cell RNA sequencing studies

    Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination

    Get PDF
    Background Vascular calcification is an organized process in which vascular smooth muscle cells (VSMCs) are implicated primarily. The purpose of the present study was to assess the effects of calcium antagonists and statins on VSMC calcification inĀ vitro. Methods VSMC calcification was stimulated by incubation in growth medium supplemented with 10Ā mmol/l Ī²-glycerophosphate, 8Ā mmol/l CaCl2, 10Ā mmol/l sodium pyruvate, 1Ā Ī¼mol/l insulin, 50Ā Ī¼g/ml ascorbic acid, and 100Ā nmol/l dexamethasone (calcification medium). Calcification, proliferation, and apoptosis of VSMCs were quantified. Results Calcium deposition was stimulated dose-dependently by Ī²-glycerophosphate, CaCl2, and ascorbic acid (all PĀ <Ā 0.01). Addition of amlodipine (0.01ā€“1Ā Ī¼mol/l) to the calcification medium did not affect VSMC calcification. However, atorvastatin (2ā€“50Ā Ī¼mol/l) stimulated calcium deposition dose-dependently. Combining treatments stimulated calcification to a degree similar to that observed with atorvastatin alone. Both atorvastatin and amlodipine inhibited VSMC proliferation at the highest concentration used. Only atorvastatin (50Ā Ī¼mol/l) induced considerable apoptosis of VSMCs. Conclusion InĀ vitro calcification of VSMCs is not affected by amlodipine, but is stimulated by atorvastatin at concentrations ā‰„10Ā Ī¼mol/l, which could contribute to the plaque-stabilizing effect reported for statins

    Tumour genomic and microenvironmental heterogeneity as integrated predictors for prostate cancer recurrence: a retrospective study

    Get PDF
    Clinical prognostic groupings for localised prostate cancers are imprecise, with 30ā€“50% of patients recurring after image-guided radiotherapy or radical prostatectomy. We aimed to test combined genomic and microenvironmental indices in prostate cancer to improve risk stratification and complement clinical prognostic factors

    Configuring PCs for the office.

    No full text
    Configure PCs, hardware and software for office use according to user tasks, their purchasing consideration and different levels in the organization
    • ā€¦
    corecore